Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

New EMEA NSAID Study Could Put Teeth In EU Labeling Suggestion

This article was originally published in The Tan Sheet

Executive Summary

The European Medicines Agency is considering whether it should pursue mandatory NSAID labeling requirements across the European Union that would warn of increased risk of thrombotic events associated with use of products in the category

You may also be interested in...



Naproxen Fares Better Than Ibuprofen In Cardiovascular-Risk Data

Traditional non-selective NSAIDs, with the exception of naproxen, carry similar cardiovascular risk to COX-2 inhibitors, according to results of a study released by the Agency for Healthcare Research & Quality (AHRQ) Sept. 25

EMEA Calls For NSAID Labeling Consistency, Notes “No New Safety Concerns”

Labeling regarding established NSAID safety concerns should be made consistent across European Union member states, the European Medicines Agency said Oct. 17

US Firms’ Reducing Allergy Claims For Infant Nutritionals Scratch FDA's Enforcement Discretion

“To the extent these claims pertain to the ingestion of peanuts, they are not consistent with the claim in the [2017] Letter of Enforcement Discretion FDA issued in response to a petition for a qualified health claim for ground peanuts and reduced risk of developing peanut allergy,” state CFSAN officials.

Topics

UsernamePublicRestriction

Register

SC143162

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel